Next-Gen Neurotechnologies: Graphene Electrodes and Magnetic Surgical Robotics in Deep Brain Neuromodulation
Dr. Dereck Mush, MD, MBA
PROCEPT BioRobotics
Develops robotic-assisted systems for the minimally invasive treatment of prostate diseases.
What they do
PROCEPT BioRobotics develops the AquaBeam Robotic System, which delivers Aquablation therapy for the treatment of benign prostatic hyperplasia. Urology clinics and hospitals purchase this system to provide automated, heat-free tissue removal, aiming to deliver predictable and consistent outcomes for patients with prostate enlargement.
The record
- Vertical
- Devices & Robotics
- Sub-segment
- Surgical robotics
- Product type
- Device
- Stage
- Public
- Headquarters
- Redwood City, USA
- Region
- North America
- Founded
- 2009
- Total funding
- $170M raised
Notable investors: Sutter Hill Ventures, Fidelity Management, T. Rowe Price, CPMG.
Also in Devices & Robotics
Related on The Signal
Dr. Dereck Mush, MD, MBA
Surgical Robotics After the Monopoly: What Changes When the Patents Expire
Dr. Dereck Mush, MD, MBA
The Table-Integrated OR: How J&J OTTAVA's FDA Clearance Challenges Intuitive's Soft-Tissue Monopoly
Dr. Dereck Mush, MD, MBA
Synthetic CT and Radiation-Free Orthopedics: The Economics of Single-Modality MRI Surgical Workflows
Dr. Dereck Mush, MD, MBA